Advertisement
Corrigendum
Open Access | 
10.1172/JCI181575
Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses
Fan Huang, Christophe Gonçalves, Margarita Bartish, Joelle Rémy-Sarrazin, Mark E. Issa, Brendan Cordeiro, Qianyu Guo, Audrey Emond, Mikhael Attias, William Yang, Dany Plourde, Jie Su, Marina Godoy Gimeno, Yao Zhan, Alba Galán, Tomasz Rzymski, Milena Mazan, Magdalena Masiejczyk, Jacek Faber, Elie Khoury, Alexandre Benoit, Natascha Gagnon, David Dankort, Fabrice Journe, Ghanem E. Ghanem, Connie M. Krawczyk, H. Uri Saragovi, Ciriaco A. Piccirillo, Nahum Sonenberg, Ivan Topisirovic, Christopher E. Rudd, Wilson H. Miller Jr., and Sonia V. del Rincón
Find articles by
Huang, F.
in:
PubMed
|
Google Scholar
|
Find articles by Gonçalves, C. in: PubMed | Google Scholar
Find articles by Bartish, M. in: PubMed | Google Scholar
Find articles by Rémy-Sarrazin, J. in: PubMed | Google Scholar
Find articles by Issa, M. in: PubMed | Google Scholar
Find articles by Cordeiro, B. in: PubMed | Google Scholar
Find articles by Guo, Q. in: PubMed | Google Scholar
Find articles by
Emond, A.
in:
PubMed
|
Google Scholar
|
Find articles by
Attias, M.
in:
PubMed
|
Google Scholar
|
Find articles by Yang, W. in: PubMed | Google Scholar
Find articles by Plourde, D. in: PubMed | Google Scholar
Find articles by Su, J. in: PubMed | Google Scholar
Find articles by Gimeno, M. in: PubMed | Google Scholar
Find articles by Zhan, Y. in: PubMed | Google Scholar
Find articles by Galán, A. in: PubMed | Google Scholar
Find articles by Rzymski, T. in: PubMed | Google Scholar
Find articles by Mazan, M. in: PubMed | Google Scholar
Find articles by Masiejczyk, M. in: PubMed | Google Scholar
Find articles by Faber, J. in: PubMed | Google Scholar
Find articles by Khoury, E. in: PubMed | Google Scholar
Find articles by Benoit, A. in: PubMed | Google Scholar
Find articles by Gagnon, N. in: PubMed | Google Scholar
Find articles by
Dankort, D.
in:
PubMed
|
Google Scholar
|
Find articles by Journe, F. in: PubMed | Google Scholar
Find articles by Ghanem, G. in: PubMed | Google Scholar
Find articles by
Krawczyk, C.
in:
PubMed
|
Google Scholar
|
Find articles by
Saragovi, H.
in:
PubMed
|
Google Scholar
|
Find articles by Piccirillo, C. in: PubMed | Google Scholar
Find articles by
Sonenberg, N.
in:
PubMed
|
Google Scholar
|
Find articles by Topisirovic, I. in: PubMed | Google Scholar
Find articles by Rudd, C. in: PubMed | Google Scholar
Find articles by Miller, W. in: PubMed | Google Scholar
Find articles by del Rincón, S. in: PubMed | Google Scholar
Published May 1, 2024 - More info
J Clin Invest. 2024;134(9):e181575. https://doi.org/10.1172/JCI181575.
© 2024 Huang et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Related article:
Abstract
Melanomas commonly undergo a phenotype switch, from a proliferative to an invasive state. Such tumor cell plasticity contributes to immunotherapy resistance; however, the mechanisms are not completely understood and thus are therapeutically unexploited. Using melanoma mouse models, we demonstrated that blocking the MNK1/2-eIF4E axis inhibited melanoma phenotype switching and sensitized melanoma to anti–PD-1 immunotherapy. We showed that phospho-eIF4E–deficient murine melanomas expressed high levels of melanocytic antigens, with similar results verified in patient melanomas. Mechanistically, we identified phospho-eIF4E–mediated translational control of NGFR, a critical effector of phenotype switching. Genetic ablation of phospho-eIF4E reprogrammed the immunosuppressive microenvironment, exemplified by lowered production of inflammatory factors, decreased PD-L1 expression on dendritic cells and myeloid-derived suppressor cells, and increased CD8+ T cell infiltrates. Finally, dual blockade of the MNK1/2-eIF4E axis and the PD-1/PD-L1 immune checkpoint demonstrated efficacy in multiple melanoma models regardless of their genomic classification. An increase in the presence of intratumoral stem-like TCF1+PD-1+CD8+ T cells, a characteristic essential for durable antitumor immunity, was detected in mice given a MNK1/2 inhibitor and anti–PD-1 therapy. Using MNK1/2 inhibitors to repress phospho-eIF4E thus offers a strategy to inhibit melanoma plasticity and improve response to anti–PD-1 immunotherapy.
Authors
Fan Huang, Christophe Gonçalves, Margarita Bartish, Joelle Rémy-Sarrazin, Mark E. Issa, Brendan Cordeiro, Qianyu Guo, Audrey Emond, Mikhael Attias, William Yang, Dany Plourde, Jie Su, Marina Godoy Gimeno, Yao Zhan, Alba Galán, Tomasz Rzymski, Milena Mazan, Magdalena Masiejczyk, Jacek Faber, Elie Khoury, Alexandre Benoit, Natascha Gagnon, David Dankort, Fabrice Journe, Ghanem E. Ghanem, Connie M. Krawczyk, H. Uri Saragovi, Ciriaco A. Piccirillo, Nahum Sonenberg, Ivan Topisirovic, Christopher E. Rudd, Wilson H. Miller Jr., Sonia V. del Rincón
Original citation: J Clin Invest. 2021;131(8):e140752. https://doi.org/10.1172/JCI140752
Citation for this corrigendum: J Clin Invest. 2024;134(9):e181575. https://doi.org/10.1172/JCI181575
The authors recently became aware that in the legend for Figure 1D, the sample number was incorrect. In addition, in Figure 3G, the loading control was incorrectly labelled. Finally, there were errors in the figure legends for the supplemental figures. The correct legend for Figure 1D and figure panel for Figure 3G appear below. The HTML and PDF versions of the article and supplemental material have been updated online.
(D) Percentages (left) and representative images (right) of Ki67-positive melanoma cells in eIF4EWT and eIF4EKI primary melanoma sections (day 50; n = 8 per genotype; scale bars: 50 μm).
The authors regret the errors.
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)